Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma
about
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.Trial watch: Immunostimulatory cytokines in cancer therapy.GD2-targeted immunotherapy and radioimmunotherapyBone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy.Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: a prospective Phase II study.Macrophages are critical effectors of antibody therapies for cancerRetinoid Chemoprevention: Who Can Benefit?Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin.Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastomaPerspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource DatabaseTumor-associated macrophages and anti-tumor therapies: complex links.Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.Investigational drugs in phase II clinical trials for the treatment of neuroblastoma.Antitumor Efficacy of Anti-GD2 IgG1 Is Enhanced by Fc Glyco-EngineeringMYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-GD2 immunotherapy.Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival.Anti-GD2 immunotherapy for neuroblastoma.Cell death-based treatment of neuroblastoma.Therapeutic Antibodies to Ganglioside GD2 Evolved from Highly Selective Germline Antibodies.ASC amino acid transporter 2, defined by enzyme-mediated activation of radical sources, enhances malignancy of GD2-positive small-cell lung cancer.A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma.Treatment and outcome of adult-onset neuroblastoma.Bevacizumab-associated Bowel Microperforation in a Patient With Neuroblastoma.A combined computational-experimental approach to define the structural origin of antibody recognition of sialyl-Tn, a tumor-associated carbohydrate antigenCAR T Cell Therapy for Neuroblastoma
P2860
Q33442162-8C786B0B-A68D-4AF1-B8AB-773F2677A7F3Q33880165-0EF0EA4A-1BE5-495C-B363-0ED69532F0E5Q34625339-42A25689-93B1-4CB2-BF07-7CCB20952956Q35102499-72B3C91E-9D6A-454D-9559-FE5A8E0C3E91Q35798960-2BD627C7-4BFC-4CBE-BDC3-E70AB5D24A29Q36213288-DFB0DCFF-FCF1-4AB5-A5F4-C273395A5180Q36236984-DC2067E7-7D8D-48BD-B6B8-4461966D4C4EQ36782374-0E73086F-B518-431C-9678-B625F6DD6ACDQ37078946-2AE6EFEA-D043-407E-B122-5BD7C82B4F36Q37105366-C75F7BE3-CB1F-4FBF-9C88-92A3C11715E5Q38766176-0DF0C98D-FEEB-4CC3-B0CF-6688C01D8E8EQ38916529-67C537A1-F61B-4853-95EC-96F02D075BB0Q40041609-E6D8A661-3956-4A89-A51A-61395024CEE7Q42415905-76FAD88F-D33D-4260-9C2E-C6E65E44F36FQ47108370-B432E30A-FB41-4B39-A6D4-10DE4F117377Q47176287-1BEBBFFF-48D5-4996-BF20-AA2E5D36564FQ47554435-575E69F2-D6CC-4AF1-BFC7-BCEBF1CC12FDQ47839039-C103FAB3-869A-4F54-B9EB-02B71D0151DCQ47945436-8F48C75C-379B-480C-B92C-8E64DD095A6CQ48277237-89084C16-464D-47ED-AF6A-5F9D56316238Q51483438-BE3559C2-5210-4B5E-8A75-1C0124CFAAB6Q52637916-2662EB6D-4CD4-4750-BC35-C0C4B96D6DC3Q53735971-9EDE3722-73E3-4340-AE55-18BE85EED442Q58061110-C24CFE7F-1997-478B-9D96-C23A04FC1ED6Q59127901-3BEE5D4A-B3AD-4997-9AE5-68EB20DE58AB
P2860
Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Key role for myeloid cells: phase II results of anti-G
@nl
Key role for myeloid cells: ph ...... t osteomedullary neuroblastoma
@ast
Key role for myeloid cells: ph ...... t osteomedullary neuroblastoma
@en
type
label
Key role for myeloid cells: phase II results of anti-G
@nl
Key role for myeloid cells: ph ...... t osteomedullary neuroblastoma
@ast
Key role for myeloid cells: ph ...... t osteomedullary neuroblastoma
@en
prefLabel
Key role for myeloid cells: phase II results of anti-G
@nl
Key role for myeloid cells: ph ...... t osteomedullary neuroblastoma
@ast
Key role for myeloid cells: ph ...... t osteomedullary neuroblastoma
@en
P2093
P2860
P356
P1476
Key role for myeloid cells: ph ...... t osteomedullary neuroblastoma
@en
P2093
Brian H Kushner
Elizabeth Chamberlain
Irene Y Cheung
Irina Ostrovnaya
Kim Kramer
Nai-Kong V Cheung
Neeta Pandit-Taskar
P2860
P304
P356
10.1002/IJC.28851
P577
2014-04-03T00:00:00Z